Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy

Ewa Moric-Janiszewska1, Grazyna Markiewicz-Łoskot

  • 1Department of Biochemistry, Medical University of Silesia, Sosnowiec, Poland.

Clinical Cardiology
|August 31, 2007
PubMed

Insights

Isolated noncompaction of the ventricular myocardium (INVM), or spongy myocardium, is a rare heart condition affecting systolic function. Genetic factors play a significant role, with mutations in several genes linked to its development and varying clinical presentations.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Isolated noncompaction of the ventricular myocardium (INVM), also known as spongy myocardium, is a rare cardiomyopathy.
  • It presents in neonatal, childhood, and adult forms, commonly involving systolic dysfunction and deep ventricular trabeculations.
  • While often sporadic, INVM can stem from chromosomal abnormalities or have familial incidence.

Purpose of the Study:

  • To elucidate the genetic underpinnings of Isolated noncompaction of the ventricular myocardium.
  • To review known genotype-phenotype correlations associated with this cardiomyopathy.
  • To provide a comprehensive overview of the genetic background of INVM.

Main Methods:

  • Literature review of genetic factors and genotype-phenotype correlations in Isolated noncompaction of the ventricular myocardium.
  • Analysis of reported mutations in genes associated with INVM.
  • Synthesis of information on familial and sporadic forms of the disease.

Main Results:

  • Identified key mutated genes implicated in INVM, including G4.5 (tafazzin), DTNA, FKBP-12, lamin A/C, and Cypher/ZASP.
  • Highlighted that the majority of adult INVM cases follow an autosomal dominant inheritance pattern.
  • Noted associations between INVM genotypes and phenotypes such as Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy, and Barth syndrome.

Conclusions:

  • Genetic mutations are central to the pathogenesis of Isolated noncompaction of the ventricular myocardium.
  • Understanding these genetic factors and their associated phenotypes is crucial for diagnosis and management.
  • Further research into the genetic landscape of INVM can improve diagnostic accuracy and therapeutic strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...